{
  "trial_id": "NCT00518882",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race/ethnicity, duration of diabetes, baseline HbA1c, body mass index (BMI), baseline fasting plasma glucose, baseline oral anti-diabetic drug regimen, history of cardiovascular disease, renal function, liver function, baseline blood pressure, baseline lipid profile (cholesterol, triglycerides).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race/ethnicity"
        ],
        [
          "Previous OAD treatment",
          "baseline oral anti-diabetic drug regimen"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "HbA1c",
          "baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Duration of diabetes",
        "Height",
        "Weight"
      ],
      "remaining_candidate_features": [
        "duration of diabetes",
        "baseline fasting plasma glucose",
        "history of cardiovascular disease",
        "renal function",
        "liver function",
        "baseline blood pressure",
        "baseline lipid profile (cholesterol, triglycerides)"
      ]
    },
    "processed-gen-response": "Age, gender, race/ethnicity, duration of diabetes, baseline HbA1c, body mass index (BMI), baseline fasting plasma glucose, baseline oral anti-diabetic drug regimen, history of cardiovascular disease, renal function, liver function, baseline blood pressure, baseline lipid profile (cholesterol, triglycerides)."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Type of Oral Anti-Diabetic Drug, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "HbA1c",
          "Baseline HbA1c"
        ],
        [
          "Previous OAD treatment",
          "Type of Oral Anti-Diabetic Drug"
        ],
        [
          "Duration of diabetes",
          "Duration of Diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Height",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Type of Oral Anti-Diabetic Drug, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes Duration, Previous Cardiovascular Disease, HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Type of Oral Anti-Diabetic Drug Treatment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Previous OAD treatment",
          "Type of Oral Anti-Diabetic Drug Treatment."
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "HbA1c",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Duration of diabetes",
        "Height",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diabetes Duration",
        "Previous Cardiovascular Disease",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Region of Enrollment, Diabetes Duration, Previous Cardiovascular Disease, HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Type of Oral Anti-Diabetic Drug Treatment."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at screening, fasting plasma glucose at screening, systolic and diastolic blood pressure, heart rate, history of cardiovascular disease, history of hypoglycaemia, current oral anti-diabetic drug treatment, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "Duration of diabetes",
          "duration of type 2 diabetes"
        ],
        [
          "HbA1c",
          "HbA1c at screening"
        ],
        [
          "Previous OAD treatment",
          "current oral anti-diabetic drug treatment"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Height",
        "Weight"
      ],
      "remaining_candidate_features": [
        "fasting plasma glucose at screening",
        "systolic and diastolic blood pressure",
        "heart rate",
        "history of cardiovascular disease",
        "history of hypoglycaemia",
        "smoking status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at screening, fasting plasma glucose at screening, systolic and diastolic blood pressure, heart rate, history of cardiovascular disease, history of hypoglycaemia, current oral anti-diabetic drug treatment, smoking status."
  }
}